Actively Recruiting
Clinical Evaluation of Frequency Allocation for Bimodal CI Users
Led by NYU Langone Health · Updated on 2025-09-02
24
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
N
NYU Langone Health
Lead Sponsor
N
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will examine experienced, bimodal cochlear implant (CI) patients who receive an alternative frequency allocation table (FAT) to determine how it improves sound quality, device satisfaction, and speech perception abilities with respect to the standard default FAT. The goal of this study is to investigate how improving place-pitch mismatch in bimodal CI users affects 1) sound quality, 2) satisfaction, and 3) speech perception.
CONDITIONS
Official Title
Clinical Evaluation of Frequency Allocation for Bimodal CI Users
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 or older
- Regular use of a cochlear implant device with at least 18 active electrodes and compliance with programming and appointments
- Received a cochlear implant at least 6 months ago and use a hearing aid in the other ear
- Pure tone average hearing loss between 30 and 70 dB at 0.5, 1, and 2 kHz in the hearing aid ear
- Use of standard FAT programs prior to study participation
- No known anatomical abnormalities in either ear
- English speaking
- No known cognitive impairments
- At least 25% of subjects should use the Cochlear EA32 electrode
You will not qualify if you...
- Under age 18
- Non-English speaking
- Cognitive impairment
- Inconsistent device usage
- Hearing loss greater than 70 dB pure tone average in the hearing aid ear
- Normal hearing or mild hearing loss in the hearing aid ear
- Use of non-standard FAT programs
- Use of any frequency transposition programming in the hearing aid
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU Langone Health
New York, New York, United States, 10016
Actively Recruiting
Research Team
M
Mario Svirsky, PhD
CONTACT
M
Megan Eitel
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here